Intratumoral Immunologic Landscape
Showing 1 - 25 of 1,190
Prospective Procurement of Tumor Tissue to Identify Novel
Enrolling by invitation
- Solid Tumors
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Colorectal Cancer Trial in Køge (Influenza Vaccines)
Completed
- Colorectal Cancer
- Influenza Vaccines
-
Køge, Zealand, DenmarkZealand University Hospital
Dec 12, 2022
Squamous Cell Carcinoma of the Head and Neck Trial in Portland (Intratumoral Ipilimumab)
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Intratumoral Ipilimumab
-
Portland, OregonPortland Providence Medical Center
Jan 8, 2023
Immune Biomarker Study for Head and Neck Cancer
Recruiting
- Head and Neck Cancer
- +4 more
- Sampling
-
Erlangen, Bavaria, Germany
- +2 more
Jan 23, 2023
MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC
Not yet recruiting
- Lung Neoplasms
- +2 more
- Tumor samples
-
Bordeaux, FranceCHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
Aug 28, 2023
HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer Trial in Milwaukee (HB-201 IT, HB-201 IV)
Recruiting
- HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
- HB-201 IT
- HB-201 IV
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jul 28, 2022
Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)
Not yet recruiting
- Neoplasms
- +7 more
- Biological G207
-
Birmingham, AlabamaChildren's of Alabama
Jun 1, 2022
Mesothelioma Trial in Houston (MEDI4736, Tremelimumab, no other name)
Pancreatic Cancer, Cancer of the Pancreas, Pancreas Cancer Trial in Saint Louis (CDX-301, CDX-1140, Research blood draw)
Recruiting
- Pancreatic Cancer
- +2 more
- CDX-301
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 17, 2023
Pulmonary Osteosarcoma Trial (RNA-LP vaccine)
Not yet recruiting
- Pulmonary Osteosarcoma
- RNA-LP vaccine
- (no location specified)
Jan 25, 2023
Gastric Adenocarcinoma Trial in Pessac (Gastrectomy)
Recruiting
- Gastric Adenocarcinoma
- Gastrectomy
-
Pessac, FranceHôpital du Haut Lévêque
Mar 23, 2023
Melanoma Trial in Madison (hu14.18-IL2, Radiation Therapy, Nivolumab)
Suspended
- Melanoma
- hu14.18-IL2
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Jan 3, 2022
Advanced Solid Tumor Trial in Boston (VAX014)
Not yet recruiting
- Advanced Solid Tumor
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 2, 2023
Dengue Transmission Through Landscape Analysis
Not yet recruiting
- Dengue
- Risk Assessment
- (no location specified)
Jun 5, 2023
Psoriasis Vulgaris, Psoriasis Trial in San Francisco (other, drug, device)
Recruiting
- Psoriasis Vulgaris
- Psoriasis
- Goeckerman Therapy
- +2 more
-
San Francisco, CaliforniaUCSF Psoriasis and Skin Treatment Center
Mar 24, 2022
Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)
Not yet recruiting
- Pancreatic Cancer
- +2 more
- DaRT seeds insertion
- (no location specified)
Sep 5, 2023
Single-cell Landscape of BALF in Severe ARDS and CARDS
Completed
- ARDS: Acute Respiratory Distress Syndrome
- Covid19
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 5, 2023
Lung Cancer Trial in Busan (Ultrathin bronchoscopy with intratumoral washing)
Not yet recruiting
- Lung Cancer
- Ultrathin bronchoscopy with intratumoral washing
-
Busan, Korea, Republic ofPusan National University hospital
Nov 17, 2023
Lung Cancer Trial in Philadelphia (AdV-tk (aglatimagene besadenovec) + valacyclovir)
Unknown status
- Lung Cancer
- AdV-tk (aglatimagene besadenovec) + valacyclovir
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 25, 2021
Esophageal Cancer Trial in Copenhagen (Calcium Gluconate)
Recruiting
- Esophageal Cancer
- Calcium Gluconate
-
Copenhagen, DenmarkRigshospitalet
Jan 17, 2022
Epiction of Genomic and Genetic Landscape Identifies CCL5
Completed
- Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5
- (no location specified)
Jan 27, 2023
Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer Trial (Radiation: Diffusing Alpha Radiation
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
- (no location specified)
Dec 11, 2022
Advanced Malignant Tumor Trial in Beijing ([ Lu-177]-Catalase)
Recruiting
- Advanced Malignant Neoplasm
- [ Lu-177]-Catalase
-
Beijing, Beijing, ChinaZhi Yang
Aug 2, 2023